HCA Healthcare Inc (HCA) Expected to Announce Earnings of $1.93 Per Share

Share on StockTwits

Equities analysts expect HCA Healthcare Inc (NYSE:HCA) to report earnings of $1.93 per share for the current quarter, according to Zacks. Ten analysts have made estimates for HCA Healthcare’s earnings. The lowest EPS estimate is $1.83 and the highest is $2.09. HCA Healthcare reported earnings of $1.21 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 59.5%. The firm is scheduled to announce its next quarterly earnings results before the market opens on Tuesday, October 30th.

On average, analysts expect that HCA Healthcare will report full year earnings of $9.23 per share for the current year, with EPS estimates ranging from $9.07 to $9.32. For the next year, analysts expect that the business will post earnings of $9.98 per share, with EPS estimates ranging from $9.39 to $10.66. Zacks’ EPS averages are an average based on a survey of sell-side analysts that that provide coverage for HCA Healthcare.

HCA Healthcare (NYSE:HCA) last released its earnings results on Wednesday, July 25th. The company reported $2.29 earnings per share for the quarter, topping the Zacks’ consensus estimate of $2.16 by $0.13. HCA Healthcare had a negative return on equity of 61.68% and a net margin of 6.21%. The company had revenue of $11.53 billion during the quarter, compared to the consensus estimate of $11.32 billion. During the same quarter in the previous year, the company posted $1.73 EPS. HCA Healthcare’s quarterly revenue was up 7.4% compared to the same quarter last year.

HCA has been the subject of several recent research reports. Credit Suisse Group boosted their price objective on HCA Healthcare from $122.00 to $143.00 and gave the company an “outperform” rating in a research report on Friday, July 27th. ValuEngine cut HCA Healthcare from a “buy” rating to a “hold” rating in a research note on Thursday, June 28th. SunTrust Banks reissued a “buy” rating and set a $125.00 target price on shares of HCA Healthcare in a research note on Friday, July 20th. Citigroup boosted their target price on HCA Healthcare from $136.00 to $156.00 and gave the company a “buy” rating in a research note on Thursday, October 11th. Finally, Royal Bank of Canada boosted their target price on HCA Healthcare to $150.00 and gave the company an “outperform” rating in a research note on Monday, September 10th. Two analysts have rated the stock with a sell rating, four have issued a hold rating and eighteen have assigned a buy rating to the stock. The stock has a consensus rating of “Buy” and a consensus target price of $135.19.

In related news, CMO Jonathan B. Perlin sold 10,000 shares of the company’s stock in a transaction on Wednesday, July 25th. The stock was sold at an average price of $112.53, for a total value of $1,125,300.00. Following the sale, the chief marketing officer now directly owns 105,394 shares of the company’s stock, valued at $11,859,986.82. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Charles J. Hall sold 34,125 shares of the company’s stock in a transaction on Friday, August 3rd. The stock was sold at an average price of $129.93, for a total value of $4,433,861.25. Following the completion of the sale, the insider now directly owns 98,124 shares in the company, valued at $12,749,251.32. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 170,257 shares of company stock worth $21,118,053. 2.80% of the stock is owned by insiders.

A number of hedge funds have recently modified their holdings of HCA. FMR LLC grew its stake in HCA Healthcare by 54.9% in the second quarter. FMR LLC now owns 5,488,273 shares of the company’s stock worth $563,097,000 after purchasing an additional 1,944,961 shares during the period. Renaissance Technologies LLC grew its stake in shares of HCA Healthcare by 187.9% in the second quarter. Renaissance Technologies LLC now owns 1,094,431 shares of the company’s stock worth $112,289,000 after acquiring an additional 714,331 shares during the last quarter. LSV Asset Management grew its stake in shares of HCA Healthcare by 9.2% in the second quarter. LSV Asset Management now owns 5,459,388 shares of the company’s stock worth $560,133,000 after acquiring an additional 457,752 shares during the last quarter. Millennium Management LLC grew its stake in shares of HCA Healthcare by 32.3% in the second quarter. Millennium Management LLC now owns 1,698,536 shares of the company’s stock worth $174,270,000 after acquiring an additional 414,877 shares during the last quarter. Finally, Massachusetts Financial Services Co. MA grew its stake in shares of HCA Healthcare by 62.6% in the second quarter. Massachusetts Financial Services Co. MA now owns 891,489 shares of the company’s stock worth $91,466,000 after acquiring an additional 343,121 shares during the last quarter. 70.44% of the stock is currently owned by institutional investors.

Shares of HCA stock opened at $136.37 on Tuesday. The company has a quick ratio of 1.15, a current ratio of 1.36 and a debt-to-equity ratio of -7.64. HCA Healthcare has a fifty-two week low of $74.26 and a fifty-two week high of $141.11. The company has a market capitalization of $47.22 billion, a price-to-earnings ratio of 17.17, a P/E/G ratio of 1.21 and a beta of 0.50.

The company also recently declared a quarterly dividend, which was paid on Friday, September 28th. Investors of record on Tuesday, September 4th were paid a $0.35 dividend. The ex-dividend date of this dividend was Friday, August 31st. This represents a $1.40 annualized dividend and a yield of 1.03%. HCA Healthcare’s payout ratio is 21.24%.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, provides health care services. The company operates general, acute care hospitals that offer medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy services.

Featured Article: Fundamental Analysis – How It Helps Investors

Get a free copy of the Zacks research report on HCA Healthcare (HCA)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.